These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6376028)

  • 1. Sulfonylurea effects on target tissues for insulin.
    McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
    Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
    Kolterman OG; Olefsky JM
    Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.
    Maloff BL; Lockwood DH
    J Clin Invest; 1981 Jul; 68(1):85-90. PubMed ID: 7019248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular loci of sulfonylurea actions.
    Lebovitz HE
    Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapancreatic action of sulfonylureas: hypoglycemic effects are not dependent on altered insulin binding or inhibition of transglutaminase.
    Nowak SM; McCaleb ML; Lockwood DH
    Metabolism; 1983 Apr; 32(4):398-402. PubMed ID: 6137754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
    Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R
    Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic insulin resistance in non-insulin-dependent diabetes mellitus and the effects of a sulfonylurea in potentiating insulin action.
    Amatruda JM; Salhanick AI; Chang CL
    Diabetes Care; 1984; 7 Suppl 1():47-53. PubMed ID: 6376029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral antidiabetic agents: recent aspects].
    Keller U; Berger W
    Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
    Albert J; Ekoé JM
    Sem Hop; 1983 Sep; 59(29-30):2135-40. PubMed ID: 6312587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
    Cam MC; Brownsey RW; Rodrigues B; McNeill JH
    Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postreceptor regulation of insulin action in primary cultures of rat hepatocytes by oral hypoglycemic agents: effects of linogliride and chlorpropamide.
    Salhanick AI; Leighty SJ; Amatruda JM
    Horm Metab Res; 1989 Nov; 21(11):596-601. PubMed ID: 2687145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonylureas enhance in vivo the effectiveness of insulin in type 1 (insulin dependent) diabetes mellitus.
    Pontiroli AE; Alberetto M; Bertoletti A; Baio G; Pozza G
    Horm Metab Res; 1984 Dec; 16 Suppl 1():167-70. PubMed ID: 6398258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hypoglycemic agents in the treatment of type II diabetes.
    Tal A
    Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B.
    Wu Y; Ou-Yang JP; Wu K; Wang Y; Zhou YF; Wen CY
    Acta Pharmacol Sin; 2005 Mar; 26(3):345-52. PubMed ID: 15715932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of glimepiride on the binding kinetics of insulin with its skeletal muscle and liver receptors in rats with short term and prolonged hyperglycemia induced by streptozotocin.
    Krauss H; Grzymisławski M; Koźlik J; Sosnowski P; Piatek J; Mikrut K; Maćkowiak P; Paluszak J
    Med Sci Monit; 2004 Jan; 10(1):BR11-6. PubMed ID: 14704628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glipizide and hepatic glycogenolysis.
    Bloch K; Daturi S; Tommasini R
    Acta Endocrinol Suppl (Copenh); 1980; 239():11-4. PubMed ID: 7001838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.